IRIS
IANNONE, ROSA FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.148
AS - Asia 480
EU - Europa 474
Continente sconosciuto - Info sul continente non disponibili 103
SA - Sud America 79
AF - Africa 17
OC - Oceania 2
Totale 2.303
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.120
SG - Singapore 186
RU - Federazione Russa 120
CN - Cina 101
IE - Irlanda 89
HK - Hong Kong 62
BR - Brasile 57
DE - Germania 56
SE - Svezia 55
VN - Vietnam 49
FR - Francia 31
BD - Bangladesh 28
IT - Italia 27
UA - Ucraina 26
FI - Finlandia 17
GB - Regno Unito 14
CA - Canada 12
CZ - Repubblica Ceca 10
IN - India 10
EC - Ecuador 8
AT - Austria 7
MX - Messico 7
NL - Olanda 6
DZ - Algeria 5
IQ - Iraq 5
PK - Pakistan 5
PL - Polonia 5
UZ - Uzbekistan 5
HN - Honduras 4
JP - Giappone 4
VE - Venezuela 4
AR - Argentina 3
CO - Colombia 3
IR - Iran 3
LT - Lituania 3
MY - Malesia 3
TR - Turchia 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
CR - Costa Rica 2
EG - Egitto 2
ES - Italia 2
ID - Indonesia 2
KG - Kirghizistan 2
MA - Marocco 2
NP - Nepal 2
SA - Arabia Saudita 2
SN - Senegal 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
EE - Estonia 1
GY - Guiana 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PW - Palau 1
RO - Romania 1
SC - Seychelles 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 2.201
Salva come PNG Salva come JPEG
Città #
Dallas 422
San Jose 199
Dublin 88
Singapore 85
Ashburn 69
Hong Kong 62
Beijing 37
Columbus 37
Chandler 34
Nyköping 34
Munich 32
Santa Clara 30
Council Bluffs 24
Los Angeles 22
Lauterbourg 20
Ho Chi Minh City 19
Hanoi 14
The Dalles 14
Helsinki 13
Jacksonville 13
Moscow 12
Phoenix 11
Brno 10
New York 10
Nuremberg 10
Chicago 7
London 7
Princeton 7
Wilmington 7
Brooklyn 6
Amsterdam 5
Falkenstein 5
Frankfurt am Main 4
Guangzhou 4
Hudson 4
Loja 4
Milan 4
Shanghai 4
Tashkent 4
Toronto 4
Turku 4
Warsaw 4
Xi'an 4
Algiers 3
Atlanta 3
Boston 3
Chennai 3
Cincinnati 3
Guayaquil 3
Hải Dương 3
Mexico City 3
Paris 3
Rio de Janeiro 3
Rome 3
Seattle 3
São Paulo 3
Tokyo 3
Vienna 3
Washington 3
Baghdad 2
Baku 2
Caracas 2
Columbia 2
Dakar 2
Dhaka 2
Foggia 2
Guiyang 2
Haiphong 2
Hangzhou 2
Hillsboro 2
Indianapolis 2
Islamabad 2
Kuala Lumpur 2
Lahore 2
Montevideo 2
Montreal 2
Naples 2
New Delhi 2
North Bergen 2
San José 2
Welland 2
Abbotsford British Columbia 1
Abuja 1
Aci Catena 1
Ahmedabad 1
Amman 1
Amparo 1
Anchorage 1
Andradina 1
Angri 1
Ankara 1
Antalya 1
Apex 1
Araçatuba 1
Arraial do Cabo 1
Aryanah 1
Ash Shuhada' 1
Astrakhan 1
Autryville 1
Azcapotzalco 1
Totale 1.520
Salva come PNG Salva come JPEG
Nome #
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 213
Nintedanib in Rheumatoid Arthritis–Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 154
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 142
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 132
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 121
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 120
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 120
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? 111
Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry 96
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA 95
Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study 92
Thoracic lymphadenopathy as possible predictor of the onset of interstitial lung disease in systemic sclerosis patients without lung involvement at baseline visit: A retrospective analysis 91
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis 88
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 78
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 75
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 74
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: A EUSTAR database analysis 73
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database 70
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs 67
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry 66
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research 65
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission 62
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study 57
Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081)) 31
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database 10
Totale 2.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.610
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202259 0 0 0 0 7 1 0 6 11 24 0 10
2022/2023205 14 11 12 5 9 20 0 22 92 5 13 2
2023/202479 4 3 6 6 8 12 0 1 0 6 7 26
2024/2025352 15 5 4 13 7 53 42 28 78 31 38 38
2025/20261.301 69 147 436 71 37 44 171 104 51 78 38 55
2026/2027244 13 67 74 90 0 0 0 0 0 0 0 0
Totale 2.303